News

Pharmabiz7h
CSIR-CFTRI, completes Phase II collection of Phenome India Health Cohort project
CSIR-CFTRI, completes Phase II collection of Phenome India Health Cohort project: Our Bureau, Bengaluru Tuesday, August 12, ...
Pharmabiz1h
Viatris receives US FDA approval for generic iron sucrose injection to treat IDA in chronic kidney disease
Viatris receives US FDA approval for generic iron sucrose injection to treat IDA in chronic kidney disease: Pittsburgh Tuesday, August 12, 2025, 18:00 Hrs [IST] Viatris Inc., a gl ...
Pharmabiz1h
Celcius Logistics enters pharma cold supply chain with Rs. 50 crore investment
Celcius Logistics enters pharma cold supply chain with Rs. 50 crore investment: Our Bureau, Mumbai Tuesday, August 12, 2025, 17:40 Hrs [IST] Celcius Logistics, India’s leading t ...
Pharmabiz2h
Cystic fibrosis treatment brings new hope for patients
The National Institute for Health and Care Excellence (NICE) has approved a new treatment for cystic fibrosis (CF), making it available to hundreds of children and adults with the condition in England ...
Pharmabiz3h
Akums reports Q1 FY26 total income of Rs. 1,051 crore with 2.4% growth, 19% YoY adjusted EBITDA growth
Akums reports Q1 FY26 total income of Rs. 1,051 crore with 2.4% growth, 19% YoY adjusted EBITDA growth: Our Bureau, Bengaluru Tuesday, August 12, 2025, 15:30 Hrs [IST] Akums Drugs ...
Pharmabiz3h
US FDA grants fast track designation to NRx Pharma’s NRX-100 for suicidal ideation in patients with depression, including bipolar depression
Wilmington, Delaware Tuesday, August 12, 2025, 16:00 Hrs [IST] ...
Pharmabiz4h
Asian Institute of Nephrology & Urology inaugurates flagship hospital in Banjara Hills, Hyderabad
Asian Institute of Nephrology & Urology inaugurates flagship hospital in Banjara Hills, Hyderabad: Our Bureau, Mumbai Tuesday, August 12, 2025, 15:00 Hrs [IST] Asian Institute of ...
Pharmabiz5h
Novartis announces both ianalumab phase III trials meets primary endpoint in patients with Sjögren’s disease
Novartis announces both ianalumab phase III trials meets primary endpoint in patients with Sjögren’s disease: Basel Tuesday, August 12, 2025, 14:00 Hrs [IST] Novartis announced ...
Pharmabiz6h
Orchestra BioMed announces rollout of US FDA-approved BACKBEAT global pivotal study protocol update significantly expanding patient eligibility
Orchestra BioMed announces rollout of US FDA-approved BACKBEAT global pivotal study protocol update significantly expanding patient eligibility: New Hope, Pennsylvania Tuesday, Au ...
Pharmabiz7h
Amphastar Pharma’s iron sucrose injection receives US FDA approval to treat iron deficiency anaemia in patients with CKD
Amphastar Pharma’s iron sucrose injection receives US FDA approval to treat iron deficiency anaemia in patients with CKD: Rancho Cucamonga, California Tuesday, August 12, 2025, ...
Pharmabiz6h
Rainbow acquires major stake in Pratiksha Hospital, Guwahati for Rs. 171 crore, to expands national footprint
Rainbow acquires major stake in Pratiksha Hospital, Guwahati for Rs. 171 crore, to expands national footprint: Our Bureau, Bengaluru Tuesday, August 12, 2025, 12:45 Hrs [IST] Rain ...
Pharmabiz5h
Lupin partners with Sandoz to market & commercialize biosimilar ranibizumab across multiple regions
Lupin partners with Sandoz to market & commercialize biosimilar ranibizumab across multiple regions: Our Bureau, Mumbai Tuesday, August 12, 2025, 13:45 Hrs [IST] Global Pharma maj ...